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Effect of Exposure to Small Pharmaceutical Promotional Items on Treatment
Preferences
Abstract
Background: Policy discussions concerning pharmaceutical promotion often assume that small
promotional items are unlikely to influence prescribing behavior. Our experiment measures whether
exposure to these items results in more favorable attitudes toward marketed products and whether
policies that restrict pharmaceutical marketing mitigate this effect.
Methods: This is a randomized controlled experiment of 352 third- and fourth-year medical students at
two US medical schools with differing policies toward pharmaceutical marketing. Participants assigned
to treatment were exposed to small branded promotional items for Lipitor (atorvastatin) without
knowledge that the exposure was part of the study. We measured differences in implicit (ie, unconscious)
attitudes toward Lipitor and Zocor (simvastatin) in exposed and control groups with the Implicit
Association Test (IAT). Self-reported attitudes were also measured, and a follow-up survey was
administered measuring attitudes toward marketing.
Results: Fourth-year students at the University of Miami Miller School of Medicine exposed to Lipitor
promotional items had more favorable implicit attitudes about that brand-name drug compared to the
control group (IAT effect: 0.66 vs 0.47; P = .05), while the effect was reversed at the University of
Pennsylvania School of Medicine (IAT effect: 0.22 vs 0.52; P = .002) where restrictive policies are in place
limiting pharmaceutical marketing (interaction effect: P = .003). No significant effect was observed
among third-year students. On a “skepticism” scale, University of Miami students held more favorable
attitudes toward pharmaceutical marketing compared to University of Pennsylvania students (0.55 vs
0.42; P
Conclusions: Subtle exposure to small pharmaceutical promotional items influences implicit attitudes
toward marketed products among medical students. We observed a reversal of this effect in the setting
of restrictive policies and more negative school-level attitudes toward marketing.
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ORIGINAL INVESTIGATION

Effect of Exposure to Small Pharmaceutical
Promotional Items on Treatment Preferences
David Grande, MD, MPA; Dominick L. Frosch, PhD; Andrew W. Perkins, PhD; Barbara E. Kahn, PhD

Background: Policy discussions concerning pharma-

ceutical promotion often assume that small promotional items are unlikely to influence prescribing behavior. Our experiment measures whether exposure to these
items results in more favorable attitudes toward marketed products and whether policies that restrict pharmaceutical marketing mitigate this effect.
Methods: This is a randomized controlled experiment
of 352 third- and fourth-year medical students at two US
medical schools with differing policies toward pharmaceutical marketing. Participants assigned to treatment were
exposed to small branded promotional items for Lipitor
(atorvastatin) without knowledge that the exposure was
part of the study. We measured differences in implicit
(ie, unconscious) attitudes toward Lipitor and Zocor (simvastatin) in exposed and control groups with the Implicit Association Test (IAT). Self-reported attitudes were
also measured, and a follow-up survey was administered measuring attitudes toward marketing.

motional items had more favorable implicit attitudes about
that brand-name drug compared to the control group (IAT
effect: 0.66 vs 0.47; P = .05), while the effect was reversed at the University of Pennsylvania School of Medicine (IAT effect: 0.22 vs 0.52; P=.002) where restrictive
policies are in place limiting pharmaceutical marketing
(interaction effect: P=.003). No significant effect was observed among third-year students. On a “skepticism” scale,
University of Miami students held more favorable attitudes toward pharmaceutical marketing compared to University of Pennsylvania students (0.55 vs 0.42; P⬍.001)
but the results were similar to those of a previously published national study (0.42 vs 0.43; P =.53).
Conclusions: Subtle exposure to small pharmaceutical

promotional items influences implicit attitudes toward
marketed products among medical students. We observed a reversal of this effect in the setting of restrictive
policies and more negative school-level attitudes toward marketing.

Results: Fourth-year students at the University of Mi-

ami Miller School of Medicine exposed to Lipitor pro-
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ISCUSSIONS ABOUT THE IN-

fluence of pharmaceutical promotion on physicians often focus on gifts
and payments of relatively large economic value. This focus is
also evident in ethics guidelines addressing pharmaceutical promotion among
many professional medical societies.1 The
underlying assumption is that smaller gifts
are unlikely to exert influence on prescribing decisions.

For editorial comment
see page 829
In contrast, a substantial body of marketing and psychology literature suggests that even trivial items can exert influence irrespective of economic value. For
example, adding a small gift such as personalized mailing labels to a solicitation
for donations has been shown to significantly increase contributions.2 In phar-
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maceutical promotion, small gifts are often tethered to branding efforts, as items
such as pens and coffee mugs display logos.
Aside from the intrinsic value of promotional items, branded materials strengthen
brand awareness and build brand equity
through a variety of largely unconscious
but powerful mechanisms.3 Nonverbal information about the brand, such as symbols or logos, is often more influential than
verbal cues. 4 Stronger brands have a
memory encoding and storage advantage
over unknown brands,5 which facilitates
the formation of strong positive associations with the brand. Strong branded products are more often in a “top-of-mind”
set of alternatives for consumers to consider.6 Strong brand awareness provides a
justifiable reason for choosing a particular brand.7,8 This research suggests that
small branded promotional items should
increase favorable attitudes for the brand
being promoted. We are unaware of studies that test these effects in a clinical con-
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text with health professionals, but many physicians, because they are medical experts, believe they are not
susceptible to these influences.5,9,10 In one survey, just
8% of physicians believed they were susceptible to influence by marketing items such as branded pens, whereas
31% of patients felt these items could influence physicians.9 The guidelines of the American Medical Association regarding gifts to physicians from industry reflect
this belief of lack of susceptibility by permitting “gifts of
minimal value.”1
We used the Implicit Association Test (IAT)11 to measure the effect of simple exposure to small, branded promotional items in the environment on treatment preferences of medical students. The IAT, described in greater
detail below, is an experimental approach designed to uncover otherwise unconscious or hidden attitudes. We studied medical students from 2 schools with differing policies toward pharmaceutical marketing (more restrictive
vs less restrictive) to test possible effect modification. We
hypothesized that medical students exposed to branded
promotional items would have more favorable attitudes
toward the branded product through the priming of positive associations. However, we hypothesized that the presence of a university policy restricting pharmaceutical marketing would mitigate the positive associations with the
branded product due to the increased awareness of persuasive marketing tactics that such a policy may evoke.
METHODS

SETTING AND PARTICIPANTS
The study used a randomized experimental design. Participants were third- and fourth-year medical students at the University of Pennsylvania School of Medicine (Penn) and the University of Miami Miller School of Medicine (Miami). We selected
these institutions because of their differing policies regarding
interactions between trainees and pharmaceutical company representatives. The University of Pennsylvania has restrictive policies in place that prohibit most gifts, meals, and samples while
Miami continues to permit such marketing practices.
Subjects were recruited by e-mail and flyers and were paid
$25 per person to participate in the study. Enrollment took place
between August 24, 2007, and April 4, 2008. The study was
approved by the Institutional Review Boards at the University
of Pennsylvania and the University of Miami.

EXPERIMENTAL PROCEDURE
Study participants were assigned to a control or primed condition based on their day of enrollment. Participants assigned to
the “primed” condition were exposed to Lipitor (atorvastatin)
branded promotional items immediately prior to completing a
computer-based study instrument. These exposures included Lipitor logos on a clipboard (used when signing in to the study room)
and notepaper (used to provide participants with their study identification number). Participants assigned to the control condition completed the same procedures but with a plain (nonbranded) clipboard and notepaper. Randomization was conducted
by day in order to avoid contamination of conditions.
We did not reveal the specific focus of the study to the participants until the entire study was complete. Participants were told
they were enrolling in a study about clinical decision making under varying conditions. Participants were asked not to discuss the

experiment with others until they were notified that the study was
complete. At that time, participants were debriefed by e-mail with
an explanation of the specific aims of the experiment.

OUTCOME MEASURES
Our study was designed to measure the influence of exposure
to branded promotional items on relative attitudes toward 2
lipid-lowering statins. We examined differences in attitudes toward Lipitor and Zocor (simvastatin) in our exposed (Lipitor
promotional items) and control groups. Lipitor is among the
most promoted brand-name statins in the United States while
simvastatin is available generically and considered to be nearly
equally effective. The study outcomes included measures of implicit and self-reported (ie, explicit) attitudes.
Implicit attitudes were evaluated with the Implicit Association Test,11-15 a widely used tool in marketing and psychology research that is thought to be resistant to social desirability bias
among research participants. Initial applications of the IAT, for
example, demonstrated the persistence of racial and gender stereotypes and prejudices, even in the face of strong conscious beliefs that such attitudes do not exist and strong social norms that
dictate they should not exist.16,17 Results from the IAT are a better predictor of intergroup discrimination (eg, biased behavior
against people of other races/ethnicities, gender, and sexual orientation based on existing attitudes and stereotypes) compared
with ostensibly similar self-report measures.13 In recent years, the
use of the IAT has been expanded to research focused on branding and marketing.18,19 Further details regarding application and
validity of the IAT have been published elsewhere13-15; a demonstration can be found at the Project Implicit Web site (https:
//implicit.harvard.edu/implicit).
Conceptually, the IAT pairs targets (eg, Lipitor and Zocor) with
attributes (eg, pleasant or unpleasant) and requires subjects to sort
corresponding images and words. Differences in reaction times
when pairing targets and attributes are a clue to implicit attitudes. For example, greater speed when Lipitor and pleasant are
paired or when Zocor and unpleasant are paired reflects a more
favorable attitude toward Lipitor than Zocor. The IAT in this study
comprised 5 related categorization tasks performed on a computer. In tasks 1 and 2, study participants learn the appropriate
behavioral response (usually a key press) for each of 4 categories: 2 categories that represent the target objects (Lipitor and Zocor) and two categories that represent the attributes (pleasant and
unpleasant). In these initial tasks, words or images representing
the target objects and attributes were presented, and participants were prompted to quickly and accurately assign each word
or image to the appropriate category using assigned computer keys.
Following those tasks, the participants completed an initial combined task in which 1 attribute and 1 target object category (eg,
pleasant and Lipitor) are assigned to 1 response button, while the
other attribute and target object categories (eg, unpleasant and Zocor) are assigned to the other. Study participants were again instructed to quickly and accurately assign the items to the appropriate response key. Following a fourth categorization that reverses
the key assignments for the target categories, study participants
then complete a final reversed combined task requiring the categorization of pleasant and Zocor on the same key, and unpleasant and Lipitor on the other key. During each task, response times
were recorded.
Explicit attitudes were assessed by self-report. Following the
IAT, participants were asked to compare Lipitor and Zocor in
5 dimensions (superiority, preference, efficacy, safety, and convenience) using an 11-point scale (Lipitor Strongly Preferred=⫹5, Zocor Strongly Preferred=−5).
Study participants were contacted by e-mail after completion of the first phase of the study with a follow-up anony-
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Table 1. Demographic Characteristics of Study Participants
No. (%) of Subjects
Characteristics

Control

Sex
Female
Male
Age, y (SD)
School
University of Pennsylvania (n=154)
University of Miami (n=198)
Training year
Third-year medical student (n=191)
Fourth-year medical student (n=161)
aP

Exposed

P Value a

91 (46.2)
80 (50.8)
25.8 (3.0)

88 (53.8)
93 (49.2)
25.5 (2.4)

78 (50.7)
93 (47.0)

76 (49.3)
105 (53.0)

.49

69 (36.1)
102 (63.4)

122 (63.9)
59 (36.7)

⬍.001

.39
.31

value from a 2 test for dichotomous variables and t test for continuous variables.

mous Internet-based survey that assessed their attitudes toward pharmaceutical marketing. The purpose was to measure
differences in attitudes among students at the 2 schools given
the differing institutional policies as a possible explanatory factor. Participants completed a 9-item previously published instrument with a 4-point scale that assessed their level of agreement with statements measuring their acceptance of and
skepticism regarding pharmaceutical marketing.20

dents. At Penn, 154 students were enrolled from a potential pool of 410 third- and fourth-year students. The
average age of participants was 25.7, with similar numbers of men and women. There were no significant differences in demographic characteristics by experimental group except for training year. Fourth-year students
were represented in greater numbers in the control group,
as were third-year students in the exposed group.

STATISTICAL ANALYSIS
IMPLICIT ATTITUDES
The primary outcome measure, the mean IAT effect, was
calculated by dividing differences in average response times
when the 2 drugs are paired with different attributes by the
pooled standard deviation as described in previously published research.21 Comparisons of the IAT effect across exposed and control groups were performed using independent-sample t tests. Results were stratified by school and
class year to account for institutional and training-year effects. Analysis of variance (ANOVA) was used to calculate
the interaction effect for school, class year, and experimental exposure. Explicit attitude measures that compared Lipitor and Zocor were combined into a Lipitor preference scale
with a range of −5 to ⫹5, with positive values reflecting a
Lipitor preference. Nonparametric tests (Mann-Whitney
tests) were used to compare means from the Lipitor preference scale across groups. Chi-squared statistics were used
to compare proportions of subjects in agreement with attitude statements in our follow-up pharmaceutical marketing survey. We collapsed the 9 items from the survey
into a 6-item scale (range, 0-1) as a measure of skepticism
toward pharmaceutical marketing. The items (1, 5-9) were
selected based on the previously published 8-school
survey to allow for a direct comparison with our results.20
All P values computed were 2-sided. All analyses were performed using the Stata software program, version 9.2
(StataCorp LP; College Station, Texas).
RESULTS

A total of 352 third- (n = 191) and fourth-year (n=161)
medical students participated in our study. The demographic characteristics of the participants are summarized in Table 1. At Miami, 198 students were enrolled
from a potential pool of 324 third- and fourth-year stu-

The results from the IAT are presented in Table 2 stratified by school and class year. Overall, students in both class
years at both schools demonstrated implicit attitudes favoring Lipitor over Zocor as reflected by the positive values even among control students. However, there were significant differences between the exposed and control groups
among fourth-year medical students at Penn and Miami.
At Miami, fourth-year students exposed to Lipitor promotional items demonstrated stronger preferences toward Lipitor compared to the control group (P=.05), a finding that
supports our first hypothesis. In contrast, Penn fourthyear students exposed to Lipitor-branded items exhibited
the opposite response, demonstrating weaker preferences
toward Lipitor compared to the control group (P=.002).
There were no significant experimental effects noted among
third-year medical students at either Penn or Miami (P=.87
and P=.44, respectively). This interaction effect of our marketing exposure with school and class year is depicted in
the Figure (P=.003).
EXPLICIT ATTITUDES
The explicit attitude Lipitor preference scale that compares Lipitor with Zocor had high internal reliability
(Cronbach ␣ = 0.80). Subjects demonstrated a preference toward Lipitor compared to Zocor independent of
our intervention (Table 3). We did not observe a significant experimental effect across the 2 groups overall
or within school–class-year strata. These results suggest
that, when students self-report their explicit preferences, they have a slight preference for Lipitor but reveal no effects from a brief exposure to branded promotional items.
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Table 2. Effect of Exposure to Promotional Items on Lipitor Preference—Implicit Attitude Measures (IAT Effect) a

University of Pennsylvania medical students
Third-year students
Fourth-year students
University of Miami medical students
Third-year students
Fourth-year students
All medical students

Control

Exposed

Branding Effect b

P Value c

0.51
0.51
0.52
0.49
0.53
0.47
0.50

0.37
0.49
0.22
0.51
0.47
0.66
0.45

−0.14
−0.02
−0.30
0.02
−0.06
0.19
−0.05

.03 d
.87
.002 e
.74
.44
.05 d
.27

a The Implicit Association Test (IAT) effect represents the difference in average IAT response times when Lipitor is paired with positive or negative attributes
divided by the pooled standard deviation.21 Larger positive numbers reflect a stronger Lipitor preference.
b Branding effect represents the difference in IAT effect between experimental groups. Positive numbers indicate an experimental effect that increased the
preference for Lipitor.
c Statistical significance denoted.
d P ⱕ .05.
e P ⱕ .01.

0.7

0.66

Lipitor Preference (IAT Effect)

0.6

Control
Exposed

0.52
0.47

0.5
0.4
0.3
0.22
0.2
0.1
0.0
Penn

Miami

Fourth-Year Medical Students

0.7

Lipitor Preference (IAT Effect)

0.6
0.51
0.5

0.53
0.49

0.47

0.4

published results from a 2005 survey20 involving thirdyear medical students from 8 schools are included for comparison. Neither Penn nor Miami students were included in this previous survey. Overall, Penn students
had less favorable attitudes toward pharmaceutical marketing compared to Miami students. For example, 63.3%
of students at Penn agreed that gifts and food from pharmaceutical sales representatives would influence their
eventual prescribing in contrast to just 29.4% at Miami
(P⬍.001). Two-thirds (66.7%) of students at Penn agreed
that the school should exclude sales representatives from
meeting with students in comparison to just 17.5% at Miami (P⬍.001). Notably, attitudes of Miami students were
similar to those from the 2005 survey involving 8 schools.
The pharmaceutical marketing skepticism scale had
high internal reliability (Cronbach ␣=0.72). University
Penn students held more skeptical views toward pharmaceutical marketing compared to Miami students (0.55
vs 0.42, P⬍.001). Miami students held similar views as
students in the previously published survey involving 8
schools (0.42 vs 0.43, P=.53), while Penn students were
more skeptical toward marketing (0.55 vs 0.43, P⬍.001).

0.3

COMMENT

0.2
0.1
0.0
Penn

Miami

Third-Year Medical Students

Figure. Lipitor preference among third- and fourth-year medical students in
exposed and control groups, as measured by the Implicit Association Test
(IAT). Higher IAT values reflect a stronger Lipitor preference relative to
Zocor. The interaction effect for experimental group with school and class
year is significant (P =.003). Penn indicates students at the University of
Pennsylvania School of Medicine; Miami, students at the University of
Miami, Miller School of Medicine

ATTITUDES TOWARD PHARMACEUTICAL
MARKETING BY SCHOOL
Of the 352 study participants, 187 (53.1%) completed
the follow-up anonymous survey assessing attitudes toward pharmaceutical marketing (Table 4). Previously

Our study finds that subtle exposures to branded pharmaceutical promotional items influences implicit attitudes of medical students toward pharmaceutical brands.
The observed effect was modified by training year and
school. Among third-year medical students, no significant experimental effects were observed. However, among
fourth-year medical students there were significant effects at both schools in our study. Students at Miami responded as we hypothesized, shifting their preferences
in the direction of the branding exposure (ie, Lipitor).
However, students at Penn had a boomerang response,
ie, a behavioral response opposite of the implied marketing intent.22 The most likely explanation for the difference across class year is that, as students advance in
their training, they begin to form attitudes toward various treatment options that can be primed with branded
promotional items. In comparison to third-year students, fourth-year students have had greater clinical ex-
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Table 3. Self-Reported (Explicit) Attitudes—Lipitor Preference Scale a
Mean Scaled Responses

University of Pennsylvania medical students
Third-year students
Fourth-year students
University of Miami medical students
Third-year students
Fourth-year students
All study participants
a Scale

Control

Exposed

Difference

P Value

0.47
0.49
0.45
0.79
0.79
0.79
0.64

0.37
0.43
0.31
0.67
0.63
0.80
0.55

0.10
0.06
0.14
0.12
0.16
−0.01
0.10

.10
.44
.12
.37
.57
.95
.13

with a range of −5 to ⫹5, with positive numbers indicating Lipitor preference and negative numbers indicating Zocor preference.

Table 4. Attitudes About Pharmaceutical Marketing by Medical School

Most grand rounds sponsored by drug companies
are helpful and educational
It is sometimes okay for students to accept gifts
and lunches from drug companies because most
students have considerable debts and minimal income
Drug company materials are a useful way to learn
about new drugs
It is sometimes okay for students to accept gifts
and lunches from drug companies because drug
companies have minimal influence on students
Funds to medical schools from drug companies are
a helpful way to lower tuition
My school should exclude pharmaceutical
representatives from meeting with students
and residents
Receiving gifts or food from pharmaceutical
representatives increases the chance that I will
eventually prescribe the drug company’s products
Receiving gifts or food from pharmaceutical
representatives increases the chances that my fellow
students will eventually prescribe the drug
company’s products
Drug company–sponsored grand rounds are often
biased in favor of the company’s products
Summary pharmaceutical marketing skepticism scale b

P Value
(Penn vs
Miami)

P Value
(Penn vs
National
Survey)

P Value
(Miami vs
National
Survey)

Penn
(n = 90)

Miami
(n = 97)

2005
National
Survey a

52.2

% in Agreement
85.6

89.0

⬍.001 c

⬍.001 c

.32

52.2

74.2

80.3

.002 c

⬍.001 c

.16

53.3

65.0

71.3

.11

⬍.001 c

.20

30.0

60.8

71.1

⬍.001 c

⬍.001 c

.04 a

44.4

54.6

53.8

.16

.09

.88

66.7

17.5

17.3

⬍.001 c

⬍.001 c

.96

63.3

29.4

31.2

⬍.001 c

⬍.001 c

.71

68.9

38.2

42.3

⬍.001 c

⬍.001 c

.44

92.2

67.7

67.4

⬍.001 c

⬍.001 c

.95

⬍.001 c

⬍.001 c

.53

0.55

Mean Scaled Score
0.42

0.43

Abbreviations: Penn, University of Pennsylvania School of Medicine; Miami, University of Miami Miller School of Medicine.
a Sample size varied by item from 663 to 808.
b Higher numbers reflect increased skepticism about pharmaceutical marketing.
c P ⱕ .01.

perience and greater exposure to their clinical teachers
and prevailing institutional practices.
The divergent effects at our 2 study schools are an interesting finding. At Penn, exposure to the branded items
produced less favorable implicit attitudes. One potential
explanation for this effect is that the strong school policy
provided an external warning about specific persuasion tactics underlying pharmaceutical marketing. This information may have motivated some form of resistance by the
audience23 that could have taken the form of simple message rejection or active counterarguing or careful message
scrutiny.24 The policy therefore may have heightened the

ability of the Penn students to exercise what has been termed
“persuasion coping effectiveness”,25 which produces a goal
within oneself to achieve one’s own current learning or attitudinal goal independently of what the marketer seems
to be trying to accomplish. The differential attitudes observed in the marketing survey, with the Penn students exhibiting significantly more negative attitudes than those in
the national sample or for the Miami students where no
policy exists, support this explanation. At Miami, where
students had more positive attitudes toward marketing, exposure to a branded promotional item likely primed more
positive implicit associations.
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While the presence or absence of a school policy is a
reasonable explanation for our findings, we cannot prove
causality nor can we exclude other school-level characteristics as alternative explanations. Nonetheless, it is notable that the attitudes of Miami students regarding pharmaceutical marketing are remarkably similar to those
outlined in the 8-school survey20 published in 2005, while
the Penn students hold considerably less favorable attitudes in the context of restrictive policies toward pharmaceutical marketing.
The lack of significant findings in our explicit attitude measures raises several interesting conclusions and
questions. First, self-reported attitudes are vulnerable to
social desirability bias. If the hypothesized effect of a marketing exposure were positive toward a brand, then we
would expect social desirability to operate in the opposite direction as the experimental effect. This may account for our null findings among fourth-year students
at Miami on explicit attitude measures in contrast to our
IAT findings. Second, the IAT is likely to be a much more
sensitive measure than explicit attitude measures. Studies that simply rely on self-reported attitudes may miss
important effects. Novel methods that provide indirect
measures of attitudes are an important addition to the
methods used to study the effects of marketing.
There are some limitations to our experiment. Most
importantly, our findings are focused on attitudes as opposed to behaviors. However, effects on attitudes are notable given that our exposure was brief and subtle, and
attitudes are known to be a significant predictor of behaviors.26 The simulation in the experimental setting of
repeated exposure to promotional items that occurs in
clinical practice would be challenging. However, implicit attitudes have been shown to more directly translate into behaviors under conditions of high cognitive load
such as time pressure, a situation common in clinical practice.27 Another limitation is that the training year differences we observed may reflect a cohort effect. Our randomization procedures also did not produce balanced
groups with respect to training year. This is likely due
to the fact it was necessary to randomize by day to avoid
contamination of experimental groups and that class training schedules may have facilitated participation on certain days. However, we addressed this imbalance by stratifying our analysis by class year. Another possible limitation
to our study is that study subjects could have been aware
of the study hypothesis despite the fact that we did not
directly reveal it. Only our self-reported explicit attitude measures would be vulnerable in this circumstance. One of the advantages of the IAT is its resistance
to such demand characteristics, which lends strength to
our findings. Finally, we are unable to draw specific conclusions regarding practicing physicians. Our study was
focused on medical students in their third and fourth years
of training, and the generalizability of our findings to practicing physicians is unknown. These limitations are balanced by significant strengths, including the randomized experimental design and novel outcome measures
that are less susceptible to bias.
In conclusion, our study is the first of which we are
aware to experimentally measure the effect of exposure
to small branded pharmaceutical promotional items on

brand preferences among medical students. Our results
provide evidence that subtle branding exposures are important and influential, as the psychology and marketing literature would suggest. Our findings are particularly notable because they are attributable to simple
exposure to promotional items independent of other effects attributable to the social relationships associated with
gifts. Our study also suggests that institutional policies,
by way of their influence on student attitudes toward marketing, could lead to different responses to branded promotional items.
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